Evaluation of Risk of hEpatocellular Carcinoma

Abroad (travel likely)Recruiting

Conditions

NASH · HCC · Genetic Predisposition

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica, Milan, Milano, Italy
Contact: Study coordinator (Luca Vittorio Carlo Valenti) · luca.valenti@policlinico.mi.it · 02 5503 6595

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Nonalcoholic Steatohepatitis (NASH) · Metabolic Dysfunction-Associated Steatohepatitis (MASH) · Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Abroad (travel likely)RecruitingPHASE1

Columbia, United States

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity

Obesity, Morbid · NASH - Nonalcoholic Steatohepatitis · Chronic Inflammation

Abroad (travel likely)Recruiting

Scottsdale, United States

Longitudinal Observational Study Of Chinese With NAFLD/NASH

Non-Alcoholic Fatty Liver Disease (NAFLD) · Non-Alcoholic Steatohepatitis (NASH)

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

Quantitative Ultrasound Techniques for Diagnosis of Nonalcoholic Steatohepatitis

Nonalcoholic Fatty Liver Disease (NAFLD) · Nonalcoholic Steatohepatitis (NASH)

Abroad (travel likely)Recruiting

Montreal, Canada